![1]()
News
Aspirin plus a DOAC may do more harm than good in some
December 8, 2019
Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication increased bleeding risks in a large cohort.
![1]()
News
Transfusion-related lung injury is on the rise in elderly patients
November 14, 2019
SAN ANTONIO – Researchers at the Food and Drug Administration examined trends in potentially life-threatening or fatal transfusion-related adverse events in patients aged 65 years and older.
![1]()
News
Dose-reduced NOACs may be safer than warfarin in some AFib patients
October 31, 2019
Are dose-reduced non–vitamin K antagonist oral anticoagulants (NOACs) safer or more effective than warfarin is in patients with atrial fibrillation who are eligible for a dose-reduced NOAC?
![1]()
News
Updated international consensus recommendations on management of acute upper GI bleeding
October 21, 2019
Updated guidelines on management of nonvariceal acute upper GI bleeding address questions on endoscopic techniques and pharmacologic management.
![1]()
News
FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients
October 15, 2019
The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.
![1]()
News
Is it safe to discharge patients with anemia?
September 23, 2019
What is the prevalence of anemia at the time of and after discharge from the hospital, and what is the associated morbidity and mortality at 6 months?
![1]()
News
Reversal agents for direct-acting oral anticoagulants
September 20, 2019
DOACs are increasingly prescribed for anticoagulation, thanks to its multiple advantages.
News
NOACs benefit early stage chronic kidney disease patients
July 15, 2019
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
![1]()
News
No reduction in PE risk with vena cava filters after severe injury
July 9, 2019
MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in patients who can be treated with prophylactic anticoagulation within 7 days after injury,” the investigators wrote.
![1]()
News
Rivaroxaban tied to higher GI bleeding than other NOACs
June 17, 2019
SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited.
